Evidence map›Paper›PMID 38569098›Full record

ArticleJournal of medicinal chemistry2024

Selective Targeting of Regulated Rhabdomyosarcoma Cells by Trinuclear Ruthenium(II)-Arene Complexes.

Athi Welsh, Karabo Serala, Sharon Prince, Gregory S Smith

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. QSAR modeling and in vitro studies of the selective action of triphenylphosphonium salts as anticancer agents against the rhabdomyosarcoma cell line.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Athi WelshDepartment of Chemistry, University of Cape Town, Rondebosch, Cape Town 7700, South Africa.
Karabo SeralaDepartment of Human Biology, Faculty of Health Science, University of Cape Town, Observatory, Cape Town 7935, South Africa.
Sharon PrinceDepartment of Human Biology, Faculty of Health Science, University of Cape Town, Observatory, Cape Town 7935, South Africa.
Gregory S SmithDepartment of Chemistry, University of Cape Town, Rondebosch, Cape Town 7700, South Africa.ORCID 0000-0002-2892-5481
University of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of benzimidazole-based trinuclear ruthenium(II)-arene complexes (

Indexed as

Antineoplastic AgentsApoptosisCoordination ComplexesRhabdomyosarcomaRutheniumAutophagyBenzimidazolesCell Line, TumorCell MovementCell ProliferationDNA DamageDrug Screening Assays, AntitumorHumansStructure-Activity RelationshipAntineoplastic AgentsBenzimidazolesCoordination ComplexesRuthenium

Identifiers

PMID38569098
PMCPMC11056987
OpenAlexW4393861896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.